November’s edition of Healthcare Global magazine is now live!

By Catherine Sturman
November’s edition of Healthcare Global magazine is now live! Take a look at the latest edition, which covers a number of companies who are disruptin...

November’s edition of Healthcare Global magazine is now live!

Take a look at the latest edition, which covers a number of companies who are disrupting the healthcare industry.

This month, our lead feature covers San Francisco-based robotics company Zipline, who have worked to launch the world’s first autonomous drone blood delivery system within Rwanda.

We also take a look at how the US Food and Drug Administration (FDA) is championing the implementation of digital healthcare solutions. With ambitions to eradicate bottlenecks created through its historic framework and existing regulations, the FDA is working to further support the innovation of new technologies to support patients.

This month, our top 10 feature profiles the highest paid pharmaceutical CEOs this year.

Be sure not to miss our other exclusive company interviews, featuring Microsoft Health, Christus Health, GE Healthcare and many more.

We sincerely hope you enjoy the issue, and as always, please tweet your feedback to @HealthcareGlbl or @Business_Chief

 

Share

Featured Articles

Comarch Diagnostic Point Boost for European Health Insurance

Healthtech specialist Comarch introduces Diagnostic Point, designed to improve health insurance across European markets

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Procurement & Supply Chain

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma